Amy Peterson

Amy Peterson, MD, currently serves as Executive Vice President and Chief Medical Officer at Exelixis since August 2023 and is a Board Member of Conquer Cancer, the ASCO Foundation. Previously, Amy held roles as a Biotech Executive Consultant and as President and Chief Operating Officer at CytomX Therapeutics. Other notable positions include Chief Development Officer and Consultant roles at various organizations, including BeiGene and Medivation where Amy was Vice President of Clinical Development. Amy's academic background includes a Fellowship in Hematology/Oncology from The University of Chicago Pritzker School of Medicine, an MD from Thomas Jefferson University, and a BA from Wesleyan University.